Prevention of acute renal failure (ARF) following allogeneic myeloablative hematopoietic cell transplantation (MHCT) using urodilatin and mannitol - A phase II trial.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY（2003）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要